Paper Review Records
All Paper Review Records
19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
102
days
Multiple primary and familial melanoma as distinct high-risk phenotypes: a retrospective cohort study
AuthorsAndrea Carugno; Giovanni Paolino; Mario Valenti; Stefano Bighetti; Vincenzo Maione; Noemi Brigenti; Lorenza Bertù; Nicola Zerbinati
Affiliations1. Department of Medicine and Surgery, University of Insubria, Italy; 2. Dermatology Unit, Ospedale di Circolo Fondazione Macchi, Italy; 3. Unit of Dermatology, IRCCS Ospedale San Raffaele, Italy; 4. Faculty of Medicine and Surgery, Università Vita-Salute San Raffaele, Italy; 5. Dermatology Unit, IRCCS Humanitas Research Hospital, Italy; 6. Department of Biomedical Sciences, Humanitas University, Italy; 7. Dermatology Department, University of Brescia, ASST Spedali Civili di Brescia, Italy; 8. Section of Dermatology and Venereology, Department of Medicine, University of Verona, Italy; 9. Department of Medicine and Innovation Technology (DiMIT), University of Insubria, Italy
108
days
Clinical application value of preconception and prenatal carrier screening in Yinchuan
AuthorsHua Han; Xiaoyan Zhu; Lifen Chai; Yingchun Ha; Fuying Zhao; Lihua Pan
Affiliations1. Yinchuan Maternity and Child Healthcare Hospital, Prenatal Diagnosis Center, China; 2. General Hospital of Ningxia Medical University, Prenatal Diagnosis Center, China
134
days
Integrated genetic identification and molecular dynamics simulations in a novel LOXL3 genetic mutation associated with Stickler syndrome
AuthorsMin Ye; Shuai Li; Rui Li; Wen Zhang; Xianglian He; Lijun Ma; Qian Li; Wenjuan Zhuang
Affiliations1. College of Basic Medicine, Ningxia Medical University, China; 2. The First Affiliated Hospital of Dali University, China; 3. Ningxia Eye Hospital, People’s Hospital of Ningxia Hui Autonomous Region, Third Clinical Medical College of Ningxia Medical University, China
91
days
A reproducible pretreatment mucosal-inflammatory-remodeling state is associated with induction-phase anti-tumor necrosis factor non-response in ulcerative colitis
AuthorsHongwei Zheng; Xin Zhuang; Wenbiao Chen
Affiliations1. Quanzhou Medical College, China; 2. Quanzhou First Hospital Affiliated to Fujian Medical University, China
121
days
Immunogenetics and TCR expression patterns together predict future T1D onset from multi-omic datasets
AuthorsLufan Yang; Alexis Lindahl; Michael Robben
Affiliations1. Department of Animal Science, University of Illinois, Urbana-Champaign, United States; 2. Division of Nutritional Science, University of Illinois, Urbana-Champaign, United States; 3. Institute for Genomic Biology, University of Illinois, Urbana-Champaign, United States
27
days
Digital death and posthumous data: a glocal, relational perspective
AuthorsAdela Toplean
Affiliations1. Department of Communication Sciences, Faculty of Letters, University of Bucharest, Romania
56
days
Five-year outcomes of next-generation sequencing implementation at a Brazilian public health system reference centre for rare diseases
AuthorsNatana Chaves Rabelo; Maria Eduarda Gomes; Isabelle Correa de Moraes; Bianca Barbosa Abdala; Daltro C. Junior; Anneliese Barth; Patrícia Correia; Daniela Koeller Rodrigues Vieira; Fernanda Rolemberg; Naiara Gomes; Tatiana S. P. C. Magalhães; Dafne Dain Gandelman Horovitz; Juan C. Llerena; Sayonara Gonzalez
Affiliations1. Laboratório de Biologia Molecular/Medicina Genômica, Centro de Genética Médica José Carlos Cabral de Almeida & Centro de Referência para Doenças Raras – Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF) - FIOCRUZ, Brazil; 2. Unidade de Genética Clínica, Centro de Genética Médica José Carlos Cabral de Almeida & Serviço de Referência para Doenças Raras – Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF) - FIOCRUZ, Brazil; 3. Laboratório de Biologia Molecular/Medicina Genômica, Centro de Genética Médica José Carlos Cabral de Almeida, Instituto Nacional de Doenças Raras - INRaras (INCT), Brazil; 4. Departamento de Genética Médica, Faculdade de Medicina de Petrópolis – UNIFASE, Brazil
58
days
Therapeutic resistance in HPV-positive oropharyngeal squamous cell carcinoma: molecular mechanisms, clinical challenges, and precision strategies
AuthorsYiming Meng; Jing Sun; Yushu Ma; Cuicui Kong
Affiliations1. Department of Central Laboratory, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, China; 2. Department of Biobank, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, China
63
days
Artificial intelligence in peptide cancer vaccine design: from neoantigen discovery to immunogenicity prediction
AuthorsPetar Brlek; Jan Kolić; Luka Bulić; Vedrana Škaro; Dragan Primorac
Affiliations1. St. Catherine Specialty Hospital, Croatia; 2. International Center for Applied Biological Research, Croatia; 3. School of Medicine, Josip Juraj Strossmayer University of Osijek, Croatia; 4. Department of Molecular Biology, Faculty of Science, University of Zagreb, Croatia; 5. Department of Oncology and Radiotherapy, University Hospital Center Zagreb, Croatia; 6. Algebra Bernays University, Croatia; 7. Faculty of Dental Medicine and Health, Josip Juraj Strossmayer University of Osijek, Croatia; 8. Eberly College of Science, The Pennsylvania State University, United States; 9. School of Medicine, University of Split, Croatia; 10. The Henry C. Lee College of Criminal Justice and Forensic Sciences, University of New Haven, United States; 11. Sana Kliniken Oberfranken, Germany; 12. School of Medicine, University of Rijeka, Croatia; 13. School of Medicine, University of Mostar, Bosnia and Herzegovina; 14. National Forensic Sciences University, India; 15. School of Medicine, University of Pittsburgh, United States
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days